DNA X, Inc. — Form 8-K/A
Filed July 9, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
This is an amended 8-K (8-K/A) filed 2026-07-09 for period ending 2026-06-29. The filing discloses unregistered equity sales (Item 3.02), material modifications to security holder rights (Item 3.03), and amendments to articles/bylaws or fiscal year change (Item 5.03). No specific dollar amounts, share counts, counterparties, or concrete terms are provided in the header/metadata; the actual amendment details require review of the complete 57.5 KB document itself, which is not fully reproduced here.
Why this rating
Amended 8-K on equity issuance and charter changes typical for small-cap; specifics unknown from metadata alone. Routine if immaterial; potentially material if large relative to $12.6M market cap—but cannot assess without full disclosure. Flag for detailed document review.
Extracted items
- 3.02
- 3.03
- 5.03 charter/bylaw change
- 8.01 other event
See more from July 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.